International Congress of Virology, Istanbul, ASV Travel Request

摘要 美国病毒学学会(ASV)希望通过这笔整笔赠款， 部分支持20名优秀的初级病毒学家参加 第十四届国际病毒学大会将于2008年8月11日至15日在 每项奖励1,500美元，总额为30,000美元。三年一度的ICV将在伊斯坦布尔举行， 土耳其，对美国来说，由最优秀的初级病毒学家代表是至关重要的。 ICV是美国初级调查人员见面和直接互动的独特机会 与国际公认的病毒学家专家以及在全体会议上学习， 研讨会和海报会议所有病毒研究的最新进展 地区，包括人类、动物、植物、昆虫和原核生物的病毒。当前 临床病毒学、艾滋病和SARS以及新发现的细小病毒和 冠状病毒，将包括在内。全体会议将讨论病毒的进入和结构， 病毒-细胞相互作用、进化、免疫生物学、发病机制、病毒与宿主 防御、病毒复制和复制的宿主因素，以及新出现的病毒和 病毒的控制。还将有专门的主题座谈会，重点是 病毒诊断方法，疫苗开发的新方法，基因治疗和 传递，和病毒作为溶瘤剂。研讨会和海报会议将讨论 所有病毒家族及其复制和发病机制，包括艾滋病毒、肝炎、 流感和冠状病毒。ASV认为一种极好的刺激和 帮助初级病毒学家在未来的工作中使他们能够直接与 世界上最好的病毒学家，由此往往产生独特的、持久的合作。 ASV主席Donald Ganem博士将任命一个遴选委员会来评判 在申请者中，将获得基于(1)ICV参与的部分差旅支持， (2)获奖者的研究将受益的前景；(3)经济需求。这个 遴选委员会将包括科学主任Dorothea Sawicki博士 这份申请书和ASV的秘书兼财务主管。令人满意的会后会议 对于成功的申请者，将需要一份详细说明其研究好处的报告。 我们的目标是为初级病毒学家提供部分资金，包括妇女和少数族裔 科学家，他们本来可能无法参加ICV，目标是受益 美国未来几年的病毒学研究。病毒学研究有很多 在传染病、免疫学、肿瘤、血液学、肺病学、 心血管、胃肠、神经学、眼科、发育和儿童 疾病，慢性和退化性疾病，以及基础遗传学， 基因组学、基因治疗和生物技术。 C：\Documents and Settings\ASV\Grant\ICV-2008\ICV Abstract.doc

Abstract The American Society for Virology (ASV) wishes to provide, through this block grant, partial support for the travel of 20 selected outstanding junior virologists to participate in the XIVth International Congress of Virology (ICV) to be held August 11-15, 2008, at a level of $1,500 per award, for a $30,000 total. This triennial ICV will be in Istanbul, Turkey, and it is essential for the U.S. to be represented by its best junior virologists. The ICV is a unique opportunity for U.S. junior investigators to meet and interact directly with internationally recognized expert virologists as well as learn in plenary sessions, workshops and poster sessions the most recent developments in all virus research areas, including viruses of humans, animals, plants, insects, and prokaryotes. Current problems in clinical virology, AIDS and SARS, and newly recognized parvoviruses and coronaviruses, will be included. Plenary sessions will cover virus entry and structure, virus-cell interactions, evolution, immunobiology, pathogenesis, virus versus host defenses, virus replication and host factors for replication, and emerging viruses and the control of viruses. There will also be special topics symposia that focus on new methods in viral diagnosis, new approaches to developing vaccines, gene therapy and delivery, and viruses as oncolytic agents. Workshop and poster sessions will address all virus families and their replication and pathogenesis, including HIV, hepatitis, influenza, and coronaviruses. The ASV considers one excellent way to stimulate and aid junior virologists in their future work is to enable them to interact directly with the best virologists world-wide, from which unique, long-lasting collaborations often result. Dr. Donald Ganem, ASV President, will appoint a selection committee to judge who among the applicants will receive partial travel support based on (1) ICV participation, (2) prospect that the awardee's research will benefit, and (3) financial need. The selection committee will include among others, Dr. Dorothea Sawicki, Scientific Director of this application and Secretary-Treasurer of the ASV. A satisfactory post-meeting report detailing the benefits to their research will be required of successful applicants. Our aim is to provide partial funding for junior virologists, including women and minority scientists, who might otherwise be unable to attend the ICV, with the goal of benefiting virological research in the U.S. for years to come. Virological research has many applications in the fields of infectious, immunologic, neoplastic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, ophalmologic, developmental and childhood diseases, and in chronic and degenerative diseases, as well as in basic genetics, genomics, gene therapy and biotechnology. C:\Documents and Settings\ASV\Grant\ICV-2008\ICV Abstract.doc